16% protein, 30% fat, 54% carbohydrate, 1000 mg calcium, and 30 mg oxalate which was devoid of vitamin C and calcium supplements. This diet limits the contribution of diet to the urinary oxalate pool. Subjects remained on this diet for 3 days. 24-hour urine collections were performed on the last two days. Urinary oxalate was measured by ion chromatography coupled with mass spectroscopy. Statistical analysis included Chi-squared, correlation and linear regression analysis, and student t-test.
INTRODUCTION AND OBJECTIVES:
The association between metabolic syndrome and consequent changes in urinary parameters have been well established. We aimed to further investigate whether these changes can be seen in pre-diabetic or pre-metabolic syndrome stone forming patients.
METHODS: We retrospectively reviewed medical records of kidney stone patients who underwent metabolic workup at a comprehensive stone clinic, including their initial 24-hour urine prior to the implementation of metabolic therapy. Patients were divided into cohorts by diabetic-status (as either non-diabetic, pre-diabetic, or diabetic) and separately divided into cohorts by Metabolic Syndrome Risk Score (MSRS). We investigated the relationships between these clinical characteristics and the patients' urine parameters and stone compositions. We performed statistical analysis between groups using one-way ANOVA and Games-Howell Post-hoc test. RESULTS: 383 stone forming patients who were treated between November, 2007 and October, 2018 were included in the study. Diabetic patients as well as patients with increasing MSRS were significantly more likely to have lower pH and increased supersaturation of uric acid but were found to have slightly higher citrate and decreased supersaturation of calcium phosphate (p<0.05). In post hoc analysis, patients with increasing individual components of the MSRS, demonstrated commensurate deviations of 24-hour urine parameters (p<0.05). Notably, these findings were seen with only a single MSRS risk factor. Patients with uric acid stones were more likely to have higher MSRS and diabetes (p<0.05).
CONCLUSIONS: Changes in urine parameters can be seen in stone formers even early in the pathogenesis of metabolic syndrome. These patients appear to have demonstrable, correctable, metabolic derangements that may place them at higher risk for recurrent stone formation. This suggests a role for early screening and intervention in first time stone formers with any signs of metabolic syndrome. The incidence of kidney stones in China has increased dramatically in recent decades. However, there is limited information on factors associated with kidney stones, particularly metabolic risk factors. We examined the association of kidney stones with new-onset hypertension, diabetes, and obesity.
METHODS: The study included Qingdao Port Cardiovascular Health Study participants who were aged more than 18 years and had an abdominal ultrasound in 2013 that was negative for kidney stones. Blood pressure, height, weight, blood lipids, and fasting plasma glucose were measured annually. Multivariable Cox regression models with timedependent covariates were used to estimate the effects of new-onset hypertension, diabetes, and obesity on the incidence of kidney stones.
RESULTS: There were 9,667 participants without kidney stones in 2013 (mean age 46.2 years; 75.6% male). During a mean follow-up of 33.5 months (range: 6-42 months), 676 (7.0%) incident cases of kidney stones were identified. Kidney stones were more frequent among those who had new-onset of a metabolic factor versus those who did not (hypertension: 7.7% vs 6.0%; diabetes: 8.4% vs 6.6%; obesity: 7.4% vs 6.8%). Adjusted Cox models identified increased risk of kidney stones with new-onset hypertension (adjusted hazard ratio [HR] 1.69, 95% confidence interval [CI] 1.25-2.27), new-onset diabetes (HR 1.78, 95% CI 1.07-2.96), and new-onset obesity (HR 1.78, 95% CI 1.15-2.74).
CONCLUSIONS: New-onset of hypertension, diabetes, and obesity increased the risk of kidney stones in this prospective cohort study. Results suggest that a substantial proportion of kidney stones are potentially preventable by appropriate control of these metabolic risk factors. 
